Trade Summary

10 months ago, Panacea Innovation Ltd, serving as 10% owner at Atara Biotherapeutics, Inc. (ATRA), purchased 19,335 shares at $9.64 per share, for a total transaction value of $186,372.00. Following this transaction, Panacea Innovation Ltd now holds 1,350,000 shares of ATRA.

This purchase represents a 1.00% increase in Panacea Innovation Ltd's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, July 17, 2025 and publicly disclosed via SEC Form 4 filing on Monday, July 21, 2025 at 9:00 AM ET, 4 days after the trade was made.

Atara Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.